USFDA approves Zydus Lifesciences to market generic Micafungin injection

The United States Food and Drug Administration (USFDA) has given its approval to market Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials, Zydus Lifesciences Ltd said in an exchange filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news